Continued Success of Venetoclax in t(11;14) Multiple Myeloma Despite Negative Trials
Multiple myeloma (MM) is a plasma cell neoplasm that remains incurable despite significant recent advances in novel and immune-based therapies.1 Although cytogenetic assessment has improved disease classification and prognostication,2 there are no …